Medtronic Plc’s recently made public that its EVP & Pres Neuroscience Wall Brett A. unloaded Company’s shares for reported $1.12 million on Jan 24 ’25. In the deal valued at $90.00 per share,12,437 shares were sold. As a result of this transaction, Wall Brett A. now holds 40,979 shares worth roughly $ 3.53 million.
Then, Wall Brett A. bought 12,437 shares, generating $1,119,330 in total proceeds.
Before that, Wall Brett A. sold 9,850 shares. Medtronic Plc shares valued at $792,038 were divested by the EVP & Pres Neuroscience at a price of $80.41 per share. As a result of the transaction, Wall Brett A. now holds 40,708 shares, worth roughly $3.5 million.
RBC Capital Mkts upgraded its Medtronic Plc [MDT] rating to an Outperform from a a Sector perform in a research note published on October 10, 2024; the price target was increased to $105 from $98. A number of analysts have revised their coverage, including Oppenheimer’s analysts, who remained covering the stock and in late August has reiterated a ‘”a Perform”‘ rating for it. UBS also remained covering MDT and has increased its forecast on August 15, 2024 with a “Neutral” recommendation from previously “Sell” rating. Stifel revised its rating on August 14, 2024. It rated MDT as “a Hold” which previously was an “a Buy”.
Price Performance Review of MDT
On Tuesday, Medtronic Plc [NYSE:MDT] saw its stock fall -7.26% to $86.07. Over the last five days, the stock has lost -5.25%. Medtronic Plc shares have risen nearly 7.75% since the year began. Nevertheless, the stocks have risen 2.86% over the past one year. While a 52-week high of $93.08 was reached on 01/28/25, a 52-week low of $75.96 was recorded on 01/06/25. SMA at 50 days reached $85.65, while 200 days put it at $85.09.
Levels Of Support And Resistance For MDT Stock
The 24-hour chart illustrates a support level at 84.61, which if violated will result in even more drops to 83.14. On the upside, there is a resistance level at 87.99. A further resistance level may holdings at 89.90. The Relative Strength Index (RSI) on the 14-day chart is 40.64, which indicates neutral technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at -0.55, which suggests price will go down in the next trading period. Percent R suggests that price movement has been bearish at 87.36%. Stochastics %K at 66.18% indicates the stock is a holding.
The most recent change occurred on May 30, 2024 when Goldman began covering the stock and recommended ‘”a Sell”‘ rating along with a $83 price target.
